Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 10-2022 | 07-2022 | 04-2022 | 01-2022 | 10-2021 | |
| Sales | 7,103 | -54,144 | 26,222 | 34,046 | 26,519 |
| Cost of Goods | 4,589 | -29,947 | 16,049 | 17,838 | 15,273 |
| Gross Profit | 2,514 | -24,197 | 10,173 | 16,208 | 11,246 |
| Operating Expenses | 7,732 | -15,008 | 13,358 | 18,969 | 13,351 |
| Operating Income | -4,629 | -10,136 | -3,136 | -1,923 | -1,832 |
| Other Income | -725 | -375 | -1,718 | -732 | -487 |
| Pre-tax Income | -5,354 | -10,511 | -4,854 | -2,655 | -2,319 |
| Net Income Continuous | -5,354 | -10,511 | -4,854 | -2,655 | -2,319 |
| Net Income Discontinuous | -5,281 | N/A | N/A | N/A | N/A |
| Net Income | $-10,635 | $-8,433 | $-4,854 | $-2,655 | $-2,319 |
| EPS Basic Total Ops | -0.22 | -0.18 | -0.10 | -0.05 | -0.05 |
| EPS Basic Continuous Ops | -0.11 | -0.22 | -0.10 | -0.05 | -0.05 |
| EPS Basic Discontinuous Ops | -0.11 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.22 | -0.18 | -0.10 | -0.05 | -0.05 |
| EPS Diluted Continuous Ops | -0.11 | -0.22 | -0.10 | -0.05 | -0.05 |
| EPS Diluted Discontinuous Ops | -0.11 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-3,827 | $-9,447 | $-2,404 | $-1,218 | $-1,131 |